文献速递主动脉外科瓣膜外科

无支架异种移植物行主动脉根部置换术后生存由患者特征决定

Survival after aortic root replacement with a stentless xenograft is determined by patient characteristics.
PubMed 文献 · J Thorac Cardiovasc Surg · 2021-07-17

该多中心回顾性研究纳入1999至2018年间6个中心使用Freestyle生物假体行全主动脉根部置换的1008例患者共1030次植入,按手术指征分层分析中期生存与再干预。结果显示择指征患者90天存活者中期生存与年龄性别标准化的一般人群无差异,而心内膜炎和A型夹层患者死亡超额;5年和8年免于瓣膜再干预率分别为95.0%和94.4%。结论提示结局由患者与疾病特征而非假体本身决定。

要点

  • 择期动脉瘤、小根等指征者中期生存与标准化一般人群无差异。
  • 心内膜炎与Stanford A型夹层患者中期死亡超额(P < .001)。
  • 5年和8年免于瓣膜再干预率分别为95.0%和94.4%。

核心结论

  • 中期随访支持Freestyle生物假体在复杂高危主动脉根部置换中的真实世界应用,结局由患者与疾病特征而非假体决定。

研究设计与样本

  • 多中心回顾性研究,1999至2018年6个北大西洋中心1008例患者共1030次Freestyle生物假体全主动脉根部置换,按指征分层。

主要发现

  • 择期指征包括动脉瘤39.8%、小根8.3%、其他13.8%,紧急/急诊指征包括心内膜炎26.7%和Stanford A型夹层11.4%。
  • 非择期病例占46.3%,再次手术占34.0%,中位年龄66.0岁(IQR 58.0-71.8),中位随访5.0年(IQR 2.6-7.9)。
  • 30天死亡率随指征不同为2.9%至27.4%。
  • 择期指征90天存活者中期生存与年龄性别标准化一般人群无差异(动脉瘤P = .95,小根P = .83,其他P = .16)。
  • 心内膜炎和A型夹层患者死亡超额(P < .001);52例(5.2%)接受再干预,多因心内膜炎。

关键数值与推荐

  • 5年和8年免于瓣膜再干预率分别为95.0%和94.4%。

临床怎么用

  • 对择期主动脉根部置换患者,Freestyle生物假体可获与一般人群相当的中期生存。
  • 心内膜炎和A型夹层患者术后中期死亡风险显著升高,需加强随访管理。

局限性

  • 回顾性设计,结果需前瞻性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Our objective was to examine intermediate-term survival and reinterventions in unselected patients, stratified according to indication, who received a Freestyle (Medtronic Inc, Minneapolis, Minn) bioprosthesis as a full aortic root replacement. METHODS: Data from medical records were retrospectively collected for patients who had aortic root replacement using Freestyle bioprostheses between 1999 and 2018 at 6 North-Atlantic centers. Survival status was extracted from national registries and results stratified according to indication for surgery. RESULTS: We included 1030 implantations in 1008 patients with elective indications for surgery: aneurysm (39.8%), small root (8.3%), and other (13.8%), and urgent/emergent indications: endocarditis (26.7%) and Stanford type A aortic dissection (11.4%). Across indications, 46.3% were nonelective cases and 34.0% were reoperations. Median age was 66.0 (interquartile range, 58.0-71.8) years and median follow-up was 5.0 (interquartile range, 2.6-7.9) years. Thirty-day mortality varied from 2.9% to 27.4% depending on indication. Intermediate survival for 90-day survivors with elective indications were not different from the general population standardized for age and sex (P = .95, .83, and .16 for aneurysms, small roots, and other, respectively). In contrast, patients with endocarditis and type A dissection had excess mortality (P < .001). Freedom from valve reinterventions was 95.0% and 94.4% at 5 and 8 years, respectively. In all, 52 patients (5.2%) underwent reinterventions, most because of endocarditis. CONCLUSIONS: At intermediate term follow-up this retrospective study provides further support for the use of the Freestyle bioprosthesis in the real-world setting of diverse, complex, and often high-risk aortic root replacement and suggests that outcome is determined by patient and disease, rather than by prosthesis, characteristics.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Dagnegård HH, Bekke K, Kolseth SM, et al. Survival after aortic root replacement with a stentless xenograft is determined by patient characteristics. J Thorac Cardiovasc Surg. 2021. PMID: 34452760. doi:10.1016/j.jtcvs.2021.07.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。